Document is current
Any future updates will be listed below
-
Authors
Palm, Denise
Smigielski, Lukasz
Uzoni, Adriana
Tucha, Oliver
Thome, Johannes
Grünblatt, Edna https://orcid.org/0000-0001-8505-7265
-
Funding
Funding for this research was provided by:
University of Zurich
- License Information
-
More Information
Article History
Received: 4 June 2025
Accepted: 7 July 2025
First Online: 21 July 2025
Change Date: 1 September 2025
Change Type: Update
Change Details: Missing supplementary file has been updated
Declarations
:
: This study was conducted in compliance with the Declaration of Helsinki. The research obtained ethical approval from the Ethical Review Committee of Rostock University (Registration number, A2013-159). Informed written consent was obtained from each study participant.
: Johannes Thome has received financial support from pharmaceutical companies (Actelion, Astra Zeneca, Bristol-Myers Squibb, EVER Neuro Pharma GmbH, Janssen-Cilag, Lilly, Lundbeck, MEDICE, Merz, Novartis, Pfizer, Roche, Servier, Shire, Trommsdorff), some of which manufacture medication used in the treatment of ADHD patients. Denise Palm, Lukasz Smigielski, Adriana Uzoni, Oliver Tucha, and Edna Grünblatt have no potential conflicts of interest to disclose.
